Cargando…
NR6A1 regulates lipid metabolism through mammalian target of rapamycin complex 1 in HepG2 cells
BACKGROUND: Lipogenesis is required for the optimal growth of many types of cancer cells, it is shown to control the biosynthesis of the lipid bilayer membrane during rapid proliferation and metastasis, provides cancer cells with signaling lipid molecules to support cancer development and make cance...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637573/ https://www.ncbi.nlm.nih.gov/pubmed/31315616 http://dx.doi.org/10.1186/s12964-019-0389-4 |
_version_ | 1783436268831506432 |
---|---|
author | Wang, Yinfang Wan, Xiaohong Hao, Yilong Zhao, Yuanyuan Du, Lanlan Huang, Yitong Liu, Zongjun Wang, Ying Wang, Nanping Zhang, Peng |
author_facet | Wang, Yinfang Wan, Xiaohong Hao, Yilong Zhao, Yuanyuan Du, Lanlan Huang, Yitong Liu, Zongjun Wang, Ying Wang, Nanping Zhang, Peng |
author_sort | Wang, Yinfang |
collection | PubMed |
description | BACKGROUND: Lipogenesis is required for the optimal growth of many types of cancer cells, it is shown to control the biosynthesis of the lipid bilayer membrane during rapid proliferation and metastasis, provides cancer cells with signaling lipid molecules to support cancer development and make cancer cells more resistant to oxidative stress-induced cell death. Though multiple lipogenic enzymes have been identified to mediate this metabolic change, how the expression of these lipogenic enzymes are transcriptionally regulated remains unclear. METHODS: Gain- and loss-of-function experiments were conducted to assess the role of transcriptional repressor, nuclear receptor sub-family 6, group A, member 1 (NR6A1) in HepG2 cells. RT-qPCR method was performed to investigate target gene of NR6A1. Western blot was employed to determine the mechanisms by which NR6A1 regulates lipid accumulation in HepG2 cells. RESULTS: We provide evidence that NR6A1 is a novel regulator of lipid metabolism in HepG2 cells. NR6A1 knockdown can increase lipid accumulation as well as insulin-induced proliferation and migration of HepG2 cells. The lipogenic effect correlated well with the expression of lipogenic genes, including fatty acid synthase (FAS), diglyceride acyltransferase-2 (DGAT2), malic enzyme 1 (ME1), microsomal triglyceride transfer protein (MTTP) and phosphoenolpyruvate carboxykinase (PEPCK). NR6A1 knockdown also increased the expression of carnitine palmitoyltransferase 1A (CPT1a), the rate-limiting enzyme in fatty acid oxidation. Furthermore, NR6A1 knockdown induced lipid accumulation through mammalian target of rapamycin complex 1 (mTORC1), but not mTORC2. Moreover, siRNA-mediated knockdown of NR6A1 increased expression of insulin receptor (INSR) and potentitated insulin-induced phosphorylation of mTOR and AKT partly via miR-205-5p in HepG2 cells. CONCLUSIONS: These findings provide important new insights into the role of NR6A1 in the lipogenesis in HepG2 cells. GRAPHICAL ABSTRACT: . [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12964-019-0389-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6637573 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66375732019-07-25 NR6A1 regulates lipid metabolism through mammalian target of rapamycin complex 1 in HepG2 cells Wang, Yinfang Wan, Xiaohong Hao, Yilong Zhao, Yuanyuan Du, Lanlan Huang, Yitong Liu, Zongjun Wang, Ying Wang, Nanping Zhang, Peng Cell Commun Signal Research BACKGROUND: Lipogenesis is required for the optimal growth of many types of cancer cells, it is shown to control the biosynthesis of the lipid bilayer membrane during rapid proliferation and metastasis, provides cancer cells with signaling lipid molecules to support cancer development and make cancer cells more resistant to oxidative stress-induced cell death. Though multiple lipogenic enzymes have been identified to mediate this metabolic change, how the expression of these lipogenic enzymes are transcriptionally regulated remains unclear. METHODS: Gain- and loss-of-function experiments were conducted to assess the role of transcriptional repressor, nuclear receptor sub-family 6, group A, member 1 (NR6A1) in HepG2 cells. RT-qPCR method was performed to investigate target gene of NR6A1. Western blot was employed to determine the mechanisms by which NR6A1 regulates lipid accumulation in HepG2 cells. RESULTS: We provide evidence that NR6A1 is a novel regulator of lipid metabolism in HepG2 cells. NR6A1 knockdown can increase lipid accumulation as well as insulin-induced proliferation and migration of HepG2 cells. The lipogenic effect correlated well with the expression of lipogenic genes, including fatty acid synthase (FAS), diglyceride acyltransferase-2 (DGAT2), malic enzyme 1 (ME1), microsomal triglyceride transfer protein (MTTP) and phosphoenolpyruvate carboxykinase (PEPCK). NR6A1 knockdown also increased the expression of carnitine palmitoyltransferase 1A (CPT1a), the rate-limiting enzyme in fatty acid oxidation. Furthermore, NR6A1 knockdown induced lipid accumulation through mammalian target of rapamycin complex 1 (mTORC1), but not mTORC2. Moreover, siRNA-mediated knockdown of NR6A1 increased expression of insulin receptor (INSR) and potentitated insulin-induced phosphorylation of mTOR and AKT partly via miR-205-5p in HepG2 cells. CONCLUSIONS: These findings provide important new insights into the role of NR6A1 in the lipogenesis in HepG2 cells. GRAPHICAL ABSTRACT: . [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12964-019-0389-4) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-17 /pmc/articles/PMC6637573/ /pubmed/31315616 http://dx.doi.org/10.1186/s12964-019-0389-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Wang, Yinfang Wan, Xiaohong Hao, Yilong Zhao, Yuanyuan Du, Lanlan Huang, Yitong Liu, Zongjun Wang, Ying Wang, Nanping Zhang, Peng NR6A1 regulates lipid metabolism through mammalian target of rapamycin complex 1 in HepG2 cells |
title | NR6A1 regulates lipid metabolism through mammalian target of rapamycin complex 1 in HepG2 cells |
title_full | NR6A1 regulates lipid metabolism through mammalian target of rapamycin complex 1 in HepG2 cells |
title_fullStr | NR6A1 regulates lipid metabolism through mammalian target of rapamycin complex 1 in HepG2 cells |
title_full_unstemmed | NR6A1 regulates lipid metabolism through mammalian target of rapamycin complex 1 in HepG2 cells |
title_short | NR6A1 regulates lipid metabolism through mammalian target of rapamycin complex 1 in HepG2 cells |
title_sort | nr6a1 regulates lipid metabolism through mammalian target of rapamycin complex 1 in hepg2 cells |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637573/ https://www.ncbi.nlm.nih.gov/pubmed/31315616 http://dx.doi.org/10.1186/s12964-019-0389-4 |
work_keys_str_mv | AT wangyinfang nr6a1regulateslipidmetabolismthroughmammaliantargetofrapamycincomplex1inhepg2cells AT wanxiaohong nr6a1regulateslipidmetabolismthroughmammaliantargetofrapamycincomplex1inhepg2cells AT haoyilong nr6a1regulateslipidmetabolismthroughmammaliantargetofrapamycincomplex1inhepg2cells AT zhaoyuanyuan nr6a1regulateslipidmetabolismthroughmammaliantargetofrapamycincomplex1inhepg2cells AT dulanlan nr6a1regulateslipidmetabolismthroughmammaliantargetofrapamycincomplex1inhepg2cells AT huangyitong nr6a1regulateslipidmetabolismthroughmammaliantargetofrapamycincomplex1inhepg2cells AT liuzongjun nr6a1regulateslipidmetabolismthroughmammaliantargetofrapamycincomplex1inhepg2cells AT wangying nr6a1regulateslipidmetabolismthroughmammaliantargetofrapamycincomplex1inhepg2cells AT wangnanping nr6a1regulateslipidmetabolismthroughmammaliantargetofrapamycincomplex1inhepg2cells AT zhangpeng nr6a1regulateslipidmetabolismthroughmammaliantargetofrapamycincomplex1inhepg2cells |